Journal of Diabetes Mellitus

Volume 9, Issue 4 (November 2019)

ISSN Print: 2160-5831   ISSN Online: 2160-5858

Google-based Impact Factor: 0.48  Citations  

The Level and Role of Interleukin-17 in Patients of Type 2 Diabetes Mellitus with and without Complications

HTML  XML Download Download as PDF (Size: 261KB)  PP. 176-185  
DOI: 10.4236/jdm.2019.94017    747 Downloads   2,691 Views  Citations

ABSTRACT

Background: Type 2 Diabetes Mellitus (T2DM) is the most prevalent metabolic disorder in the world. Recent evidence however suggests that T2DM is not only a disease of metabolism, but also an inflammatory disorder and that inflammation also plays an important role in the pathogenesis of Diabetic complications. Our aim was to study the level of interleukin-17 (IL 17) in Indian populations with T2DM as an inflammatory marker and analyze its role in different diabetic complications. Methods: A total of consecutive 67 patients of T2DM were evaluated for clinical parameters fasting blood glucose (FBG), 2hr-post-prandial blood glucose (PPBG), lipid profile, HbA1c and plasma IL 17. They were divided into three groups—Patients of T2DM without any complications (group A; n = 24), T2DM with acute complications (group B; n = 20), T2DM with chronic complications (group C; n = 23) and compared with 23 healthy controls (group D). Results: Diabetic patients had a higher level of IL 17 as compared to the healthy controls. The level of IL 17 in complicated diabetics was higher than the patients with T2DM without complications. Multiple logistic regression analysis showed positive correlation of IL 17 with Diabetic Retinopathy and Diabetic Neuropathy. IL 17 also showed a positive Pearsons correlation with systolic blood pressure (SBP), diastolic blood pressure (DBP), serum triglycerides (TG), serum total cholesterol (TC), very low density lipoproteins (VLDL), low density lipoproteins (LDL), HbA1c and a negative correlation with HDL. Conclusion: Indian subjects with T2DM with or without complications had higher values of IL 17 as compared to healthy controls. Also diabetic neuropathy and diabetic retinopathy were positively correlated to levels of IL 17. Further levels of IL 17 were positively correlated to hypertension and dyslipidemia indicating a prevalent inflammatory state in our population of T2DM with and without complications.

Share and Cite:

Parhi, A. , Das, S. , Mahapatra, S. , Pradhan, N. , Behera, M. , Patnaik, B. and Rattan, R. (2019) The Level and Role of Interleukin-17 in Patients of Type 2 Diabetes Mellitus with and without Complications. Journal of Diabetes Mellitus, 9, 176-185. doi: 10.4236/jdm.2019.94017.

Cited by

[1] Immunological profile of diabetic foot ulcers: update review
Razzaq, MH Hussein - Muthanna Medical Journal, 2023
[2] Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY)
in vivo, 2022
[3] Cytokine profiling for Egyptian diabetic patients with nephropathy
Journal of Medicine in …, 2022
[4] The promising role of microbiome therapy on biomarkers of inflammation and oxidative stress in type 2 diabetes: a systematic and narrative review
Frontiers in …, 2022
[5] Association of Interleukin-17A Genotypes with their Serum Levels in Iraqi Type 2 Diabetic Patients
Wasit Journal of Pure sciences, 2022
[6] A holistic view of the goto-kakizaki rat immune system: decreased circulating immune markers in non-obese type 2 diabetes
Frontiers in …, 2022
[7] Relations between Interlukin-6 and Some Biochemical Parameters in Diabetic Foot Syndrome
2021
[8] Relations between Interleukin-6 and Some Biochemical Parameters in Diabetic Foot Syndrome.
Salih, ZM Ali - Medico-Legal Update, 2021
[9] Alcohol Consumption as a Risk Factor for the Development of Type 2 Diabetes Mellitus in Patients at Hospital Central de Nampula, Northern Mozambique
2020
[10] Evaluate microbial profile and IL-17 level in transmission transfusion infection patients
[11] Evaluation of Serum IL-17A Levels in Diabetes with Chronic Periodontitis Patients.(2022)
[12] УТИЦАЈ КВАЛИТЕТА МЕТАБОЛИЧКЕ КОНТРОЛЕ НА ИСХОД ЛЕЧЕЊА ФИЗИКАЛНИМ ПРОЦЕДУРАМА БОЛЕСНИКА СА ГОНАРТРОЗОМ И ДИЈАБЕТЕС …

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.